Histopathological comparison of the effects of histidine and ketotifen in a rat model of colitis

Bulletin of the Veterinary Institute in Pulawy

Volumn 53, Issue 4, 2009, Pages 795-800

  Farshid, Amir Abbas ^a   Tamaddonfard, Esmaeal ^a   Belasius, Melika Sadat ^a   Hamzeh Gooshchi, Nasrin ^a  

^a URMIA UNIVERSITY   (Iran)

Author keywords

Colitis; Histidine; Histopathology; Ketotifen; Rats

Indexed keywords

RATTUS;

EID: 77949290156     PISSN: 00424870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Andou A., Hisamatsu T., Okamoto S., Chiuen H., Kamada N., Kobayashi T., Hashimoto M., Okutsu T., Shimbo K., Takeda T., Matsumoto H., Sato A., Ohtsu H., Suzuki M., Hibi T.: Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages. Gastroenterology 2009, 136, 564-574.
2. Bene L., Sapi Z., Bajtai A., Buzas E., Szentmihalyi A., Arato A., Tulassay Z., Falus A.: Partial protection against dextran sodium sulfate induced colitis in histamine-deficient, histidine decarboxylase knockout mice. J Pediatr Gastroenterol Nutr 2004, 39, 171-176.
3. Eliakim R., Karmedi F., Okon E., Rachmilewitz D.: Ketotifen effectively prevents mucosal damage in experimental colitis. Gut 1992, 33, 1498-1503.
4. Eliakim R., Karmeli F., Okon E., Rachmilewitz D.: Ketotifen ameliorates capsaicin-augmented acetic-acidinduced colitis. Dig Dis Sci 1995, 40, 503-509.
5. Elson C.O., Sartor R.B., Tennyson G.S., Riddell R.H.: Experimental models of inflammatory bowel disease. Gastroenterology 1995, 109, 1344-1367.
6. Ewaschuk J.B., Dieleman L.A.: Probiotics and prebiotics in chronic inflammatory bowel disease. World J Gastroenterol 2006, 12, 5941-5950.
7. Faure M., Mettraux C., Moennoz D., Godin J.P., Vuichoud J., Rochat F., Breuille D., Obled C., Corthesy- Theulaz I.: Specific amino acids increase mucin synthesis and microbiota in dextran sulfate sodium-treated rats. J Nutr 2006, 136, 1558-1564.
8. Fogel W.A., Wagner W., Sasiak K., Stasiak A.: The role of histamine in experimental ulcerative colitis in rats. Inflamm Res 2005, 54, 68-69.
9. Gilles S., Zahler S., Welsch U., Sommerhoff C.P., Becker B.F.: Release of TNF-alpha during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers. Cardiovasc Res 2003, 60, 608- 616.
10. Giris M., Depboylu B., Dugero-Abbasoglu S., Erbil Y., Olgac V., Alis H., Aykac-Toker G., Uysal M.: Effect of taurine on oxidative stress and apoptosis-related protein expression in trinitrobenzene sulphonic acid-induced colitis. Clin Exp Immunol 2008, 152, 102-110.
11. Grants S.M., Goa K.L., Fitton A., Sorkin E.M.: Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders. Drugs 1990, 40, 412-448.
12. Hanauer S.B.: Inflammatory bowel disease: epidemiology, pathogenesis and therapeutic opportunities. Inflamm Bowel Dis 2006, 12, 3-9.
13. Hendrickson B.A., Gokhale R., Cho J.H.: Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 2002, 15, 79-94.
14. Hiraga N., Adachi N., Liu K., Nagaro T., Arai T.: Suppression of inflammatory cell recruitment by histamine receptor stimulation in ischemic rat brains. Eur J Pharmacol 2007, 557, 236-244.
15. Huang C.H., Suen J.L., Hua Y.M., Chiang W., Chang H.C., Chen C.N., Jong Y.J.: Suppressive effect of ketotifen on Th1 and Th2-related chemokines of monocytes. Pediatr Allergy Immunol 2007, 18, 378-384.
16. Ikeda Y., Mochizuki Y., Matsumoto H., Nakamura Y., Dohi K., Jimbo H., Shimazu M., Hayashi M., Matsumoto K.: L-histidine but not D-histidine attenuates brain edema following cryogenic surgery in rats. Acta Neurochir Suppl 2000, 76, 195-197.
17. Iuvone T., Van Den Bossche R., D'Acquisto F., Carnuccio R., Herman A.: Evidence that mast cell degranulation, histamine and tumor necrosis factor α release occur in LPS-induced plasma leakage in rat skin. Br J Pharmacol 1999, 128, 700-704.
18. Jones N.L., Roifman C.M., Griffiths A.M., Sherman P.: Ketotifen therapy for acute ulcerative colitis in children: a pilot study. Dig Dis Sci 1998, 43, 609-615.
19. Kawada M., Arihiro A., Mizoguchi E.: Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J Gastroenterol 2007, 13, 5581-5593.
20. Klebanov G.I., Teselkin Yu O., Babenkova I.V., Lyubitsky O.B., Rebrova O.Y., Boldyrev A.A., Vladimirov Y.A.: Effect of carnosine and its components on free-radical reactions. Membr Cell Biol 1998, 12, 89- 99.
21. Liu W.H., Liu T.C., Yin M.C.: Beneficial effects of histidine and carnosine on ethanol-induced chronic liver injury. Food Chem Toxicol 2008, 46, 1503-1509.
22. MacPherson B.R., Pfeiffer C.J.: Experimental production of diffuse colitis in rats. Digestion 1978, 17, 135-150.
23. Papadakis K.A.: Chemokines in inflammatory bowel disease. Curr Allergy Asthma Rep 2004, 2004, 4, 83-89.
24. Pavlick K.P., Laroux F.S., Fuseler J., Wolf R.E., Gray L., Hoffman J., Grisham M.B.: Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic Biol Med 2002, 33, 311-322.
25. Peterson J.W., Boldogh I., Popov V.L., Saini S.S., Chopra A.K.: Anti-inflammatory and anti-secretory potential of histidine in Salmonella-challenged mouse small intestine. Lab Invest 1998, 78, 523-534.
26. Shen Y., Zhang S., Fu L., Hu W., Chen Z.: Carnosine attenuates mast cell degranulation and histamine release induced by oxygen-glucose deprivation. Cell Biol Funct 2007, 26, 334-338.
27. Singh A.P., Singh M., Balakumar P.: Effect of mast cell stabilizer in hyperhomocysteinemia-induced cardiac hypertrophy in rats. J Cardiovasc Pharmacol 2008, 51, 596-604.
28. Son D.O., Satsu H., Shimizu M.: Histidine inhibits oxidative stress and TNF alpha induced interleukin-8 secretion in intestinal epithelial cells. FEBS Lett 2005, 579, 4671-4677.
29. Tamaddonfard E., Rahimi S.: Central effect of histamine and peripheral effect of histidine on the formalin-induced pain response in mice. Clin Exp Pharmacol Physiol 2004, 31, 518-522.
30. Vicario M., Amat C., Rivero M., Moreto M., Pelegri C.: Dietary glutamine affects mucosal functions in rats with mild DSS-induced colitis. J Nutr 2007, 137, 1931-1937.
31. Wade A.M., Tucker H.N.: Antioxidant characteristics of L-histidine. J Nutr Biochem 1998, 9, 308-315.
32. Wu X.L., Ding M.P., Zhu-Ge Z.B., Zhu Y.Y., Jin C.L., Chen Z.: Carnosine, a precursor of histidine, ameliorates pentylenetetrazole-induced kindled seizures in rats. Neurosci Lett 2006, 400, 146-149.
33. Yamada Y., Sannohe S., Saito N., Cui C.H., Ueki S., Oyamada H., Kanda A., Yamaguchi K., Hamada K., Adachi T., Kayaba H., Chihara J.: Effect of ketotifen on the production of reactive oxygen species from human eosinophils primed by eotaxin. Pharmacology 2003, 69, 138-141.
34. Yamamoto-Furusho J.K.: Innovative therapeutics for inflammatory bowel disease. World J Gastroenterol 2007, 13, 1893-1896.
35. Zi-qing H., Xoi-liong G., Pin-jie H., Jing W., Ning S., Wan-ling G.: Influence of ketotifen, cromolyn sodium, and compound 48/80 on the survival rates after intestinal ischemia reperfusion injury in rats. BMC Gastroenterol 2008, 8, 1-11.